Using ePrognosis to estimate 2-year all-cause mortality in older women with breast cancer: Cancer and Leukemia Group B (CALGB) 49907 and 369901 (Alliance A151503) Academic Article uri icon

Overview

MeSH Major

  • Breast Neoplasms

abstract

  • ePrognosis tool only modestly overestimates mortality rate in older breast cancer patients enrolled in two cooperative group studies. This tool, which estimates non-cancer mortality risk based on readily available clinical information may inform adjuvant therapy decisions but should be validated in non-clinical trial populations.

publication date

  • March 10, 2017

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC5508575

Digital Object Identifier (DOI)

  • 10.1007/s10549-017-4188-6

PubMed ID

  • 28283904

Additional Document Info

start page

  • 1

end page

  • 8